Pfizer, Inc.

Form 483 issued July 23, 2015 · Rochester, Michigan

Observations
2
Pages
1
FEI number
1876582

In short: On July 23, 2015, FDA issued a Form 483 with 2 observations to Pfizer, Inc. in Rochester, Michigan (FEI 1876582). The investigators were Emily J. Orban and Rebecca E. Dombrowski. Most observations concern quality system and production; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

Quality system and production account for 2 of 2 observations.

Quality system1
Production1

Most cited: 21 CFR 211.22 (1×) · 211.111 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    Time limits are not established when appropriate for the completion of each production phase to assure…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Pfizer, Inc.?

FDA listed 2 observations on this Form 483, mostly about quality system and production. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected Pfizer, Inc.?

Emily J. Orban and Rebecca E. Dombrowski are named on this Form 483. Each investigator has a profile showing what they cite most.

When was Pfizer, Inc. inspected by FDA?

This Form 483 is dated July 23, 2015.

How do I get the full Form 483 for Pfizer, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free